Drug Information

Drug General Information
Drug ID
D0PB4P
Former ID
DIB002638
Drug Name
XM-323
Synonyms
DM-323; DMP-323; JCR-424
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Discontinued in Phase 1 [545218]
Company
Bristol-Myers Squibb Pharma Co
Structure
Download
2D MOL

3D MOL
Formula
C35H38N2O5
Canonical SMILES
C1(=O)N([C@@H]([C@@H]([C@H]([C@H](N1Cc1ccc(cc1)CO)Cc1cc<br />ccc1)O)O)Cc1ccccc1)Cc1ccc(cc1)CO
CAS Number
CAS 151867-81-1
PubChem Compound ID
132943
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [533902]
References
Ref 545218Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002483)
Ref 533902In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor. Antimicrob Agents Chemother. 1993 Dec;37(12):2606-11.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.